|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06667 MEGA GENOMICS
Nominal 
7.710 +0.010 (+0.130%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 151,300 | 3.824% | 145,727 | 237,185 | 203,220 | 123,700 |
| Cost of Sales | (63,004) | -1.562% | (64,004) | (70,509) | (56,979) | (45,224) |
| Gross Profit | 88,296 | 8.043% | 81,723 | 166,676 | 146,241 | 78,476 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 11,579 | -- | (25,852) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | (15,516) | (20,167) | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 36,179 | -- | (21,418) | 95,882 | 94,903 | 38,292 | |
| Taxation | (6,141) | -- | 3,800 | (16,867) | (15,806) | (8,601) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 30,038 | -- | (17,618) | 79,015 | 79,097 | 29,691 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 400 | -- | (667) | 6,641 | 16,207 | 19,550 |
| Depreciation & Amortisation | 15,120 | -1.034% | 15,278 | 13,873 | 14,036 | 14,054 |
| Directors' Emoluments | 8,623 | 30.770% | 6,594 | 1,166 | 320 | 754 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 14.000 | -- | -9.000 | 62.000 | -- | -- |
| DPS (cts) | 0.000 | -- | 0.000 | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.773 | -- | (0.034) | 0.241 | -- | -- |
| NBV per share ($) | 2.709 | -- | 2.583 | -- | -- | -- |
| Remarks: | Real time quote last updated: 13/11/2024 16:32 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 36,969,000 |
| %Change | 5.274% |
| EPS / (LPS) | RMB 0.180 |
| NBV Per Share (¥) | RMB 2.804 |